Christopher McNulty's most recent trade in VBI Vaccines Inc. was a trade of 75,000 Option (Right to Buy Common Shares) done . Disclosure was reported to the exchange on Jan. 26, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| VBI Vaccines Inc. | Christopher McNulty | Director, CFO and Head of BD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 75,000 | 75,000 | - | - | Option (Right to Buy Common Shares) | |
| VBI Vaccines Inc. | Christopher McNulty | Director, CFO and Head of BD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2022 | 400,000 | 400,000 | - | - | Option (Right to Buy Common Shares) | |
| VBI Vaccines Inc. | Christopher McNulty | Director, CFO and Head of BD | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2021 | 500,000 | 500,000 | - | - | Option (Right to Buy Common Shares) |